A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab
- Andrew Blauvelt
- Rundong Jiang
- Linyu Shi
- Lam C. Tsoi
- Rachael Bogle
- Jennifer Fox
- Mehrnaz Gharaee-Kermani
- Allison C. Billi
- Robert T. Matheson
- Huzefa Photowala
- Johann E. Gudjonsson
- Benjamin D. Ehst
2025-12-11